Cancer patients missing out on best treatment because of cost
Cancer patients are missing out on high-tech radiotherapy because the NHS is struggling to invest in staff and technology.Intensity modulated radiotherapy, which has been used in Europe and the US for a decade, is used to treat only 7 per cent of eligible NHS patients, according to research by the ...
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant
- 10 expert briefings every fortnight (Premium only)
Already a subscriber? Sign into your account here